Searched for
GROWTH IN PHARMACEUTICALS
From nasal delivery to sterile injectables: Biodeal Pharmaceuticals’ expansion plansBiodeal Pharmaceuticals is set to broaden its horizons with a state-of-the-art sterile injectables plant in Himachal Pradesh. This venture ...- ETMarkets Smart Talk: Smallcap investors should consider a five-year SIP horizon amid volatility: Sorbh GuptaIn an interview with Kshitij Anand of ETMarkets, Sorbh Gupta, Head of Equity at Bajaj Asset Management Limited, says investors considering ...
- Every bad cycle ends the same way; problems find their own solutions: 5 large-cap stocks with upside potential of up to 27%What should you focus on when headwinds blow? Not the share price, and not the morning's news. It should be the business and the quality of...
- Himadri Speciality Chemicals plans Rs 1,613-cr capacity expansion across key businessesHimadri Speciality Chemicals Ltd is implementing a growth strategy focused on capacity expansion and investment. The company plans to inves...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThe last few weeks have made one thing clear. Oil prices, US bond yields, corporate earnings, and the state of the world – all point the sa...
- ETMarkets Smart Talk| India’s next wealth creators may be hidden in specialised manufacturing and energy infrastructure: Paresh BhagatParesh Bhagat, Chairman of Mangal Keshav Financial Services, discusses where India’s next wealth creators could emerge from, why several mi...
- India-New Zealand FTA comes into effect todayThe FTA will provide Indian exporters with 100% duty-free access to the New Zealand market, opening opportunities for MSMEs, women entrepre...
- Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select playersIndia's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceuti...
- Charting the global economy: Inflationary pressures mount in USA broad upswing in consumer prices last month helps reinforce expectations for additional Federal Reserve interest-rate increases in the mo...
- ETMarkets Smart Talk | Manufacturing, healthcare and financialisation could create India’s next wealth creators: Sanjay DoshiAbakkus Mutual Fund’s Sanjay Doshi sees opportunities across market capitalisations, despite elevated mid- and smallcap valuations. He urge...
- 5 stocks with consistent score improvement and upside potential of up to 29 % in 1 year, according to analystsLook at how the market treated the stock of a large FMCG stock – one the best wealth creators of the past – just because it mentioned the r...
- Donald Trump raised stakes in drug companies gaining from medicare exemptions, say DemocratsInvestments in pharmaceutical companies on behalf of Donald Trump saw a significant increase after returning to the White House. His portfo...
- The $50-billion question: Who gets what as India and Canada aim to strike a trade deal?India and Canada are currently negotiating a free trade agreement designed to enhance bilateral trade significantly. Nearly 300 Canadian bu...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...
- Long-term investing is about looking beyond narratives, including AI: 5 large-caps with an upside potential of up to 24%As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...
- Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launchBiocon announced a settlement with Genentech over its biosimilar, Pebrilzo, of the cancer drug Perjeta. The agreement allows Biocon to laun...
- No love for the middle: CPHI Milan exposes India’s pharma scaling challengeIndian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...
- Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watchIndia's CRDMO sector is on the brink of expansion, backed by solid partnerships with major pharmaceutical players and comprehensive capabil...
- NuSynth Technologies raises Rs 36.5 crore in round led by Avaana Capital, Shastra VCThe company is developing a platform to find simpler, cheaper and more efficient ways to make chemicals, said cofounders Poorvank Purohit a...
- From pharma to Scotch whisky, UK has "huge" export potential in India: Commerce Minister Piyush GoyalSpeaking at the India-UK JETCO Business Plenary on Monday, Goyal highlighted the complementary nature of the two economies and stressed the...
Load More
